You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low grade non-muscle invasive bladder cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Homewood, Alabama
  • +4 more
Dec 15, 2022

Bladder Cancer Cell Transitional, Non-Muscle Invasive Bladder Cancer, Bladder Cancer Trial in United States (TSD-001)

Completed
  • Bladder Cancer Cell Transitional
  • +9 more
  • Tucson, Arizona
  • +4 more
Jan 18, 2022

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Jul 14, 2023

Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

Recruiting
  • Urinary Bladder Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • Cystoscopy
    • +2 more
    • (no location specified)
    Apr 4, 2023

    Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

    Recruiting
    • Non Muscle Invasive Bladder Cancer
    • N803 plus Bacillus Calmette-Guerin (BCG)
    • Honolulu, Hawaii
      Island Urology
    Aug 7, 2023

    Non-Muscle Invasive Bladder Cancer Trial in Aarhus (Laser ablation)

    Recruiting
    • Non-Muscle Invasive Bladder Cancer
    • Laser ablation
    • Aarhus, Denmark
      Aarhus University Hospital
    Aug 5, 2022

    High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

    Not yet recruiting
    • High-risk Non-muscle Invasive Bladder Cancer
    • (no location specified)
    Oct 25, 2023

    Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

    Not yet recruiting
    • Non-muscle Invasive Bladder Cancer
    • Chengdu, Sichuan, China
      West China Hospital
    Aug 10, 2023

    Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

    Recruiting
    • Urothelial Carcinoma
    • Non-Invasive Bladder Urothelial Carcinoma
    • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
    • Tampa, Florida
      Moffitt Cancer Center
    Mar 2, 2023

    Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • +2 more
    • PDD-TURBT with hexaminolevulinate (Hexvix®)
    • Power Led Saphira (TM) from KARL STORZ
    • (no location specified)
    Jul 24, 2023

    Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Sep 9, 2022

    Bladder Cancer Trial in Nara, Okayama (FE 999326)

    Recruiting
    • Bladder Cancer
    • FE 999326
    • Nara, Japan
    • +1 more
    Jan 19, 2023

    Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

    Completed
    • Urinary Bladder Cancer
    • +4 more
    • Neutrophil to lymphocyte ratio
    • Cairo, Egypt
      Ain Shams university
    Jul 15, 2023

    Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

    Not yet recruiting
    • Muscle-Invasive Bladder Carcinoma
    • +2 more
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Aug 3, 2023

    Non-muscle-invasive Bladder Cancer Trial in Xi'an (Standard infusion chemo, BL - 5 ala PDT)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • Standard infusion chemotherapy
    • BL - 5 ala PDT
    • Xi'an, Shaanxi, China
      Dalin He
    Sep 19, 2022

    Non-muscle-invasive Bladder Cancer Trial (STM-416)

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Jan 25, 2023

    Non-muscle Invasive Bladder Cancer Trial (TARA-002)

    Not yet recruiting
    • Non-muscle Invasive Bladder Cancer
    • TARA-002
    • (no location specified)
    Aug 24, 2022

    Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

    Recruiting
    • Bladder Cancer
    • Pseudomonas aeruginosa
    • Jinan, Shandong, China
      Qilu hospital
    Jul 26, 2023

    Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

    Not yet recruiting
    • Non-Muscle- Invasive Bladder Cancer
    • Durvalumab
    • BCG
    • (no location specified)
    Jul 5, 2023

    BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

    Recruiting
    • Bladder Cancer
      • Little Rock, Arkansas
      • +2 more
      Aug 6, 2023

      Bladder Cancer Trial in Roskilde (Urine test)

      Recruiting
      • Bladder Cancer
        • Roskilde, Denmark
          Zealand University Hospital
        Oct 5, 2022

        Uromonitor asBiomarker for Optimization of NMIBC Management by

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
          • (no location specified)
          May 9, 2023

          Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

          Not yet recruiting
          • Non-muscle-invasive Bladder Cancer
          • BCG combined with Tislelizumab
          • Shanghai, Shanghai, China
            Ruijin Hospital, Shanghai Jiaotong University School of Medicine
          Oct 12, 2022